1. Home
  2. PMT vs TBPH Comparison

PMT vs TBPH Comparison

Compare PMT & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PennyMac Mortgage Investment Trust of Beneficial Interest

PMT

PennyMac Mortgage Investment Trust of Beneficial Interest

N/A

Current Price

$9.50

Market Cap

879.9M

Sector

Real Estate

ML Signal

N/A

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

N/A

Current Price

$16.95

Market Cap

908.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PMT
TBPH
Founded
2009
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
879.9M
908.9M
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
PMT
TBPH
Price
$9.50
$16.95
Analyst Decision
Hold
Buy
Analyst Count
5
6
Target Price
$13.50
$18.40
AVG Volume (30 Days)
1.3M
486.4K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
13.33%
N/A
EPS Growth
N/A
279.13
EPS
0.40
N/A
Revenue
$351,067,000.00
$15,386,000.00
Revenue This Year
N/A
$8.46
Revenue Next Year
$1.55
N/A
P/E Ratio
$24.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.05
$13.08
52 Week High
$13.80
$21.03

Technical Indicators

Market Signals
Indicator
PMT
TBPH
Relative Strength Index (RSI) 45.16 55.26
Support Level $9.05 $16.80
Resistance Level $9.83 $17.17
Average True Range (ATR) 0.25 0.04
MACD 0.04 0.00
Stochastic Oscillator 62.42 70.00

Price Performance

Historical Comparison
PMT
TBPH

About PMT PennyMac Mortgage Investment Trust of Beneficial Interest

PennyMac Mortgage Investment Trust is a specialty finance company that invests mainly in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Share on Social Networks: